Ikegami Ichiko, Mitsuhashi Koike Yuka, Hayashi Hideki, Hirokawa Sachiko, Ando Shoichiro, Ishihara Tomohiko, Onodera Osamu
Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata, Japan.
Front Neurol. 2025 Apr 9;16:1564856. doi: 10.3389/fneur.2025.1564856. eCollection 2025.
Dentatorubral-pallidoluysian atrophy (DRPLA) is a progressive neurodegenerative disorder caused by expanded CAG repeats in the gene, characterized by cerebellar ataxia, seizures, tremors, and myoclonus. Although approximately 10% of patients with DRPLA reportedly develop schizophrenia-like psychosis (SLP), the distinct association between the clinical course of DRPLA and SLP remains unclear. This study aimed to elucidate the clinical features of SLP in patients with DRPLA.
We reviewed 22 cases of pathologically or genetically confirmed DRPLA with SLP, including 21 from the literature and one from our institution. Patient data, including clinical features, treatment information, and disease course, were extracted and analyzed.
The age of onset was categorized as juvenile ( = 6), early adult ( = 8), and late adult ( = 8). Initially, 10 patients presented with motor symptoms, with six exhibiting psychiatric symptoms and six with both motor and psychiatric symptoms simultaneously. Furthermore, three patients were initially diagnosed with schizophrenia, while four experienced progressive worsening of psychiatric symptoms. The number of CAG repeats ranged from 57 to 76 (mean, 66.0) in the 10 patients with a genetic diagnosis. Summarily, 12 patients received psychotropic medications, with nine showing improvement in delusions and hallucinations.
SLP can manifest across all DRPLA forms (juvenile-, early adult-, and late adult-onset) and may precede or follow motor symptoms. The clinical course and efficacy of psychotropic medications in patients with DRPLA and SLP suggest a shared pathogenesis between DRPLA and schizophrenia.
齿状核红核苍白球路易体萎缩症(DRPLA)是一种由该基因中CAG重复序列扩增引起的进行性神经退行性疾病,其特征为小脑共济失调、癫痫发作、震颤和肌阵挛。尽管据报道约10%的DRPLA患者会出现精神分裂症样精神病(SLP),但DRPLA临床病程与SLP之间的明确关联仍不清楚。本研究旨在阐明DRPLA患者中SLP的临床特征。
我们回顾了22例经病理或基因确诊的伴有SLP的DRPLA病例,其中21例来自文献,1例来自我们机构。提取并分析了患者数据,包括临床特征、治疗信息和疾病病程。
发病年龄分为青少年期(n = 6)、成年早期(n = 8)和成年晚期(n = 8)。最初,10例患者出现运动症状,6例有精神症状,6例同时出现运动和精神症状。此外,3例患者最初被诊断为精神分裂症,4例患者的精神症状逐渐加重。10例有基因诊断的患者中,CAG重复序列数量在57至76之间(平均66.0)。总体而言,12例患者接受了精神药物治疗,9例患者的妄想和幻觉症状有所改善。
SLP可在所有DRPLA形式(青少年期、成年早期和成年晚期发病)中出现,且可能先于或后于运动症状出现。DRPLA合并SLP患者的临床病程及精神药物疗效提示DRPLA与精神分裂症之间存在共同的发病机制。